These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 24447864)

  • 41. Cytokines and Prognostic Factors in Epithelial Ovarian Cancer.
    Jammal MP; Martins-Filho A; Silveira TP; Murta EF; Nomelini RS
    Clin Med Insights Oncol; 2016; 10():71-6. PubMed ID: 27512342
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunohistochemical staining of tumor necrosis factor-α and interleukin-10 in benign and malignant ovarian neoplasms.
    Jammal MP; DA Silva AA; Filho AM; DE Castro Côbo E; Adad SJ; Murta EF; Nomelini RS
    Oncol Lett; 2015 Feb; 9(2):979-983. PubMed ID: 25624918
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immune Biomarkers in Blood from Sarcoma Patients: A Pilot Study.
    Munisamy S; Radhakrishnan AK; Ramdas P; Samuel PJ; Singh VA
    Curr Oncol; 2022 Aug; 29(8):5585-5603. PubMed ID: 36005179
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gasotransmitters in the tumor microenvironment: Impacts on cancer chemotherapy (Review).
    Salihi A; Al-Naqshabandi MA; Khudhur ZO; Housein Z; Hama HA; Abdullah RM; Hussen BM; Alkasalias T
    Mol Med Rep; 2022 Jul; 26(1):. PubMed ID: 35616143
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Potential Role of iNOS in Ovarian Cancer Progression and Chemoresistance.
    Kielbik M; Szulc-Kielbik I; Klink M
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30970628
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Significance of TNF-α and the Adhesion Molecules: L-Selectin and VCAM-1 in Papillary Thyroid Carcinoma.
    Kobawala TP; Trivedi TI; Gajjar KK; Patel DH; Patel GH; Ghosh NR
    J Thyroid Res; 2016; 2016():8143695. PubMed ID: 26881177
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in ovarian cancer: correlation with clinical outcome.
    Raspollini MR; Amunni G; Villanucci A; Boddi V; Baroni G; Taddei A; Taddei GL
    Gynecol Oncol; 2004 Mar; 92(3):806-12. PubMed ID: 14984945
    [TBL] [Abstract][Full Text] [Related]  

  • 49. VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection.
    Engels K; du Bois A; Harter P; Fisseler-Eckhoff A; Kommoss F; Stauber R; Kaufmann M; Nekljudova V; Loibl S
    J Clin Pathol; 2009 May; 62(5):448-54. PubMed ID: 19126566
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunohistochemical visualization of pro-inflammatory cytokines and enzymes in ovarian tumors.
    Plewka D; Kowalczyk AE; Jakubiec-Bartnik B; Morek M; Bogunia E; Kmiec A; Wierzbicki PM; Plewka A
    Folia Histochem Cytobiol; 2014; 52(2):124-37. PubMed ID: 25007180
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic significance of iNOS in epithelial ovarian cancer.
    Anttila MA; Voutilainen K; Merivalo S; Saarikoski S; Kosma VM
    Gynecol Oncol; 2007 Apr; 105(1):97-103. PubMed ID: 17174383
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation of cytokines and inducible nitric oxide synthase expression with prognostic factors in ovarian cancer.
    Martins Filho A; Jammal MP; Côbo Ede C; Silveira TP; Adad SJ; Murta EF; Nomelini RS
    Immunol Lett; 2014; 158(1-2):195-9. PubMed ID: 24447864
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biologic prognostic factors in ovarian cancer: a review.
    Framarino dei Malatesta ML; Veneziano M; Peppicelli M; Lanzi G; Marzetti L
    Eur J Gynaecol Oncol; 1998; 19(2):123-5. PubMed ID: 9611049
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.